Indications |
Intramuscular Prevent formation of antibodies against foetal rhesus-positive RBCs in a rhesus-negative mother during childbirth, abortion or certain other sensitising events Adult: 500 units as soon as possible after birth. An additional dose may be required depending on the amount of transplacental bleeding as assessed by the Kleihauer test; for bleeds >4 ml, an additional 125 units for each ml of RBCs will be required. Intramuscular Routine antenatal prophylaxis Adult: 2 doses of 500 units to be given at wk 28th and 34th of gestation. Intramuscular Transfusion of D-positive blood components to rhesus-negative women of child-bearing potential Adult: 125 units/ml of transferred cells. Intravenous Idiopathic thrombocytopenic purpura Adult: Initially, 250 units/kg, may be given in 2 divided doses on separate days. Maintenance doses: 125-300 units/kg depending on the clinical response. |
Contraindications |
Splenectomised or rhesus-negative patients, in whom the resultant haemolysis may exacerbate pre-existing anaemia. Hypersensitivity. |
Warnings / Precautions |
For postpartum usage, it is to be used only for maternal admin. Not for rhesus-positive individuals. Patients should be observed for 20 minutes after admin. |
Adverse Reactions |
Hypersensitivity reactions such as hives, wheezing, urticaria, Pain and tenderness at inj site. Fever, chills, nausea, facial flushing, headache. Potentially Fatal: Intravascular haemolysis. Anaphylaxis reactions. |
Drug Interactions |
Live vaccines should only be admin at least 3 mth after the last dose of immunoglobulin admin. See Below for More anti-d immunoglobulins Drug Interactions |
Lab Interactions |
May affect the results of blood typing and antibody testing such as Coomb's test or antiglobulin test. |
Mechanism of Actions |
Anti-D immunoglobulin prevents a rhesus-negative mother from actively forming antibodies to foetal rhesus-positive RBCs that may pass into the maternal circulation during childbirth, abortion, or certain other sensitising events. It is also used in idiopathic thrombocytopenic purpura to prevent excessive bleeding. |
Available As |
|
Human Anti-D Immoune globulin
Post Review about Human Anti-D Immoune globulin Click here to cancel reply.
Human Anti-D Immoune globulin Containing Brands
Human Anti-D Immoune globulin is used in following diseases
Drug - Drug Interactions of Human Anti-D Immoune globulin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.